Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03304262 · ClinicalTrials.gov registry record · NA

Metaplasticity Experimental Design and Comparison of Motor Outcome Measure Sensitivity to Change

A NA study of Healthy, sponsored by University of New Mexi.

Completed
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT03304262 is a NA study of Healthy that has completed, run by University of New Mexi. The registered enrollment target is 13 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03304262, a NA study of Healthy, has completed, sponsored by University of New Mexi.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

The overall objective is to validate the methodology of a metaplasticity experimental design by assessing change in motor excitability after administration of priming transcranial direct current stimulation (tDCS) followed by repetitive transcranial magnetic stimulation (rTMS) in healthy human participants.

Conditions Studied

Interventions

  • DEVICE rTMS

Study Locations (1)

New Mexico

  • University of New Mexico - Albuquerque

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2017-07-18
Est. Completion 2018-03-31
Phase NA

Sponsor

University of New Mexi

76 total trials

What the Registry Record Tells You About NCT03304262

The ClinicalTrials.gov registry entry for NCT03304262 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The listed sponsor is University of New Mexi, which has 76 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which rTMS is the first listed.

NCT03304262 reports 1 study location spanning 1 distinct geographic area - top geographies include New Mexico.

Frequently Asked Questions

What is clinical trial NCT03304262 about?

NCT03304262 is a clinical study titled "Metaplasticity Experimental Design and Comparison of Motor Outcome Measure Sensitivity to Change". The overall objective is to validate the methodology of a metaplasticity experimental design by assessing change in motor excitability after administration of priming transcranial direct current stimulation (tDCS) followed by repetitive transcranial magnetic stimulation (rTMS) in healthy human parti...

What is the current status of trial NCT03304262?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2017-07-18. Estimated completion is 2018-03-31.

What conditions does trial NCT03304262 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT03304262?

The interventions under investigation include: rTMS (DEVICE).

Who is sponsoring clinical trial NCT03304262?

This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03304262 being conducted?

This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.